Improvement of ischemic cholangiopathy in three patients with hereditary hemorrhagic telangiectasia following treatment with bevacizumab

Journal of Hepatology

Volumn 59, Issue 1, 2013, Pages 186-189

  Vlachou, Paraskevi A ^a   Colak, Errol ^a   Koculym, Alexander ^a   Kirpalani, Anish ^a   Kim, Tae Kyoung ^b   Hirschfield, Gideon M ^c,d   Faughnan, Marie E ^a,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Anti VEGF; Cholangitis; Hereditary hemorrhagic telangiectasia

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; BILIRUBIN; C REACTIVE PROTEIN; FRESH FROZEN PLASMA; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; LACTULOSE; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; NARCOTIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; URSODEOXYCHOLIC ACID; VANCOMYCIN;

ADULT; ANEMIA; ANGIODYSPLASIA; ANOREXIA; ARGON PLASMA COAGULATION; ARTICLE; BACTEREMIA; BILE DUCT DISEASE; BILIRUBIN BLOOD LEVEL; BILOMA; BLOOD CULTURE; CASE REPORT; CHOLANGITIS; CHOLESTASIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOCARDIOGRAPHY; ENTEROBACTER CLOACAE; ENTEROCOCCUS; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GENETIC SCREENING; HEART MURMUR; HEPATOMEGALY; HIGH OUTPUT HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INTRACTABLE PAIN; ISCHEMIC CHOLANGIOPATHY; LEUKOCYTOSIS; LIVER TRANSPLANTATION; MELENA; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PHYSICAL EXAMINATION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RENDU OSLER WEBER DISEASE; REPEAT PROCEDURE; SEIZURE; TELANGIECTASIA; TREATMENT DURATION; UPPER ABDOMINAL PAIN; WEIGHT REDUCTION;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BILE DUCT DISEASES; BILE DUCTS, INTRAHEPATIC; FEMALE; HUMANS; ISCHEMIA; LIVER TRANSPLANTATION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879145590     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.02.006     Document Type: Article

References (14)

1. A.E. Guttmacher, D.A. Marchuk, and R.I. White Jr. Hereditary hemorrhagic telangiectasia N Engl J Med 333 1995 918 924
2. A.A. Ianora, M. Memeo, C. Sabba, A. Cirulli, A. Rotondo, and G. Angelelli Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement Radiology 230 2004 250 259
3. G. Garcia-Tsao, J.R. Korzenik, L. Young, K.J. Henderson, D. Jain, and B. Byrd Liver disease in patients with hereditary hemorrhagic telangiectasia N Engl J Med 343 2000 931 936
4. J.S. Wu, S. Saluja, G. Garcia-Tsao, A. Chong, K.J. Henderson, and R.I. White Jr. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients AJR Am J Roentgenol 187 2006 W399 W405
5. E. Buscarini, G. Leandro, D. Conte, C. Danesino, E. Daina, and G. Manfredi Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia Dig Dis Sci 56 2011 2166 2178
6. M.E. Faughnan, V.A. Palada, G. Garcia-Tsao, U.W. Geisthoff, J. McDonald, and D.D. Proctor International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia J Med Genet 48 2011 73 87
7. H. Sadick, F. Riedel, R. Naim, U. Goessler, K. Hormann, and M. Hafner Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression Haematologica 90 2005 818 828
8. P. Bose, J.L. Holter, and G.B. Selby Bevacizumab in hereditary hemorrhagic telangiectasia N Engl J Med 360 2009 2143 2144
9. S. Dupuis-Girod, I. Ginon, J.C. Saurin, D. Marion, E. Guillot, and E. Decullier Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output JAMA 307 2012 948 955
10. C.L. Shovlin, A.E. Guttmacher, E. Buscarini, M.E. Faughnan, R.H. Hyland, and C.J. Westermann Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) Am J Med Genet 91 2000 66 67
11. G.W. Erkelens, F.P. Vleggar, W. Lesterhuis, H.R. van Buuren, and S.D. van der Werf Sclerosing pancreato-cholangitis responsive to steroid therapy Lancet 354 1999 43 44
12. B. McInroy, A.B. Zajko, and A.D. Pinna Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia AJR Am J Roentgenol 170 1998 413 415
13. R.W. Blewitt, C.M. Brown, and J.I. Wyatt The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia Histopathology 42 2003 265 269
14. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936